Skip to main content

Table 1 Sociodemographic and clinical characteristics and VEGF of participants

From: Neurocognition and social cognition in remitted first-episode schizophrenia: correlation with VEGF serum levels

 RSNRSHCStatistic
(n = 65)(n = 45)(n = 58)
Age (years)29.3 ± 10.031.6 ± 13.431.4 ± 12.0F = 0.698, P = 0.499
Male/Female35/3026/1937/21χ2 = 1.256, P = 0.534
Education (years)10.8 ± 3.510.6 ± 3.611.8 ± 2.9F = 1.861, P = 0.159
Smoker/non-smoker38/2725/2032/26χ2 = 0.160, P = 0.923
BMI (kg/m2)25.0 ± 3.723.7 ± 4.624.3 ± 4.4F = 1.335, P = 0.266
Age of onset (years)25.9 ± 8.723.4 ± 8.6/t = 1.345, P = 0.234
Family history of mental disorders (yes/no)11/5411/34/χ2 = 0.940, P = 0.332
chlorpromazine equivalent375.1 ± 130.5478.8 ± 180.8 t = 3.298, P = 0.001
VEGF (pg/mL)422.8 ± 130.5351.6 ± 121.8438.6 ± 213.8F =4.014 P = 0.020